Alec Pierce, the 26‑year‑old wide receiver who helped the Indianapolis Colts reach the playoffs last season, has not taken a single snap in preseason workouts. The team announced in March that he underwent surgery on his right ankle, and a second platelet‑rich plasma injection was administered in June as the injury continued to cause discomfort.
Medical staff initially projected a four‑to‑six‑month recovery window, but as the calendar turned to August the player remains on the rehabilitation list, and General Manager Chris Ballard has not provided a new timetable since a July 28 update.
The Colts demonstrated faith in Pierce’s ability to stretch the field by rewarding him with a contract that averages more than $28 million per year, a deal that reflects his status as a premier deep‑threat option.
Fantasy analysts have labeled him a high‑risk, high‑reward asset, especially after quarterback Daniel Jones suffered a season‑ending injury that could reshape target distribution. Some draft boards are already eyeing Josh Downs as a safer alternative, citing his consistent production and PFF ranking.
Recovery Stalled
Without a clear return date, the team’s offensive scheme may have to lean on other playmakers, and the lack of on‑field reps could affect timing routes that are crucial for a receiver who thrives on big‑play opportunities.
As draft season approaches, the conversation around Pierce’s health will likely dominate discussions about the Colts’ receiving corps, making his eventual activation a pivotal storyline for both the club and its supporters.